Taysha Gene Therapies to Release First Quarter 2021 Financial Results and Host Conference Call and Webcast on May 11
Taysha Gene Therapies (Nasdaq: TSHA) has announced a conference call for a corporate update and to report its financial results for Q1 2021, scheduled for May 11, 2021, at 8:00 AM ET. The company focuses on AAV-based gene therapies for monogenic CNS diseases and is dedicated to translating scientific advancements into curative medicines. Taysha aims to leverage its partnership with UT Southwestern Gene Therapy Program to enhance its gene therapy pipeline, addressing both rare and large patient populations.
- None.
- None.
Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (“Taysha”), a patient-centric, clinical-stage gene therapy company focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the central nervous system (CNS) in both rare and large patient populations, today announced that it will report its financial results for the first quarter ended March 31, 2021, and host a corporate update conference call and webcast on Tuesday, May 11, 2021, at 8:00 AM Eastern Time.
| Conference Call Details | ||
| Tuesday, May 11, at 8:00 AM Eastern Time / 7:00 AM Central Time | ||
Toll Free: |
|
855-327-6837 |
International: |
|
631-891-4304 |
Conference ID: |
|
10014460 |
Webcast: |
|
|
About Taysha Gene Therapies
Taysha Gene Therapies (Nasdaq: TSHA) is on a mission to eradicate monogenic CNS disease. With a singular focus on developing curative medicines, we aim to rapidly translate our treatments from bench to bedside. We have combined our team’s proven experience in gene therapy drug development and commercialization with the world-class UT Southwestern Gene Therapy Program to build an extensive, AAV gene therapy pipeline focused on both rare and large-market indications. Together, we leverage our fully integrated platform—an engine for potential new cures—with a goal of dramatically improving patients’ lives. More information is available at www.tayshagtx.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210504005337/en/
FAQ
When will Taysha Gene Therapies report its Q1 2021 financial results?
What conference call details were announced by Taysha Gene Therapies?
What is Taysha Gene Therapies' focus?
What is Taysha Gene Therapies' stock symbol?
